跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CILOQUIN ciprofloxacin 3mg/mL (as hydrochloride) ear drops - TGA Drug Approval Details
Approvals
/
TGA
/
CILOQUIN ciprofloxacin 3mg/mL (as hydrochloride) ear drops
Approved
STANDARD
CILOQUIN ciprofloxacin 3mg/mL (as hydrochloride) ear drops
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
c67f2b3840bcd17e
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c67f2b3840bcd17e
Product Name
CILOQUIN ciprofloxacin 3mg/mL (as hydrochloride) ear drops
Artg Id
121898
Artg Name
CILOQUIN ciprofloxacin 3mg/mL (as hydrochloride) ear drops bottle
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2006-05-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
c67f2b3840bcd17e
Type
Standard
Back to TGA Approvals
